$77.2 Million is the total value of Belmont Global Advisors, Inc.'s 70 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 83.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FBIO | Sell | FORTRESS BIOTECH INC | $1,068,000 | -31.5% | 382,800 | -36.2% | 1.38% | -47.7% |
| SBUX | Sell | STARBUCKS CORP | $1,021,000 | -20.2% | 17,000 | -24.4% | 1.32% | -39.1% |
| SYN | Sell | SYNTHETIC BIOLOGICS INC | $801,000 | -35.8% | 350,000 | -36.4% | 1.04% | -51.0% |
| MDGN | Sell | MEDGENICS INC | $391,000 | -67.7% | 65,000 | -58.1% | 0.51% | -75.4% |
| BX | Exit | BLACKSTONE GROUP L P | $0 | – | -9,300 | -100.0% | -0.50% | – |
| WMB | Exit | WILLIAMS COS INC DEL | $0 | – | -10,000 | -100.0% | -0.62% | – |
| ISBC | Exit | INVESTORS BANCORP INC NEW | $0 | – | -40,000 | -100.0% | -0.84% | – |
| CFG | Exit | CITIZENS FINL GROUP INC | $0 | – | -21,500 | -100.0% | -0.87% | – |
| TEL | Exit | TE CONNECTIVITY LTD | $0 | – | -8,700 | -100.0% | -0.88% | – |
| XRT | Exit | SPDR SERIES TRUSTs&p retail etf | $0 | – | -12,350 | -100.0% | -0.93% | – |
| FLT | Exit | FLEETCOR TECHNOLOGIES INC | $0 | – | -4,000 | -100.0% | -0.93% | – |
| JAH | Exit | JARDEN CORP | $0 | – | -11,250 | -100.0% | -0.93% | – |
| KRE | Exit | SPDR SERIES TRUSTs&p regl bkg | $0 | – | -13,500 | -100.0% | -0.94% | – |
| QSR | Exit | RESTAURANT BRANDS INTL INC | $0 | – | -15,750 | -100.0% | -0.96% | – |
| MTB | Exit | M & T BK CORP | $0 | – | -5,000 | -100.0% | -1.04% | – |
| LNG | Exit | CHENIERE ENERGY INC | $0 | – | -15,000 | -100.0% | -1.23% | – |
| MLPL | Exit | UBS AG JERSEY BRANCH2xmn alr mlp inf | $0 | – | -30,000 | -100.0% | -1.25% | – |
| AVGO | Exit | AVAGO TECHNOLOGIES LTD | $0 | – | -6,000 | -100.0% | -1.27% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -40,000 | -100.0% | -1.30% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB CO | $0 | – | -15,000 | -100.0% | -1.51% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -5,000 | -100.0% | -1.51% | – |
| XLY | Exit | SELECT SECTOR SPDR TRsbi cons discr | $0 | – | -15,000 | -100.0% | -1.89% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -17,000 | -100.0% | -2.83% | – |
| WWAV | Exit | WHITEWAVE FOODS CO | $0 | – | -70,000 | -100.0% | -4.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ZIOPHARM ONCOLOGY INC | 12 | Q3 2016 | 21.1% |
| INTREXON CORP | 12 | Q3 2016 | 13.1% |
| FACEBOOK INC | 12 | Q3 2016 | 3.4% |
| PIMCO DYNAMIC INCOME FD | 11 | Q3 2016 | 2.2% |
| SYNERGY PHARMACEUTICALS DEL | 11 | Q3 2016 | 1.4% |
| CBIZ INC | 11 | Q2 2016 | 0.2% |
| ZIOPHARM ONCOLOGY INC | 10 | Q3 2016 | 14.8% |
| LA JOLLA PHARMACEUTICAL CO | 10 | Q2 2016 | 3.4% |
| APPLE INC | 10 | Q3 2016 | 3.2% |
| MEDGENICS INC | 10 | Q2 2016 | 2.1% |
View Belmont Global Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-08-15 |
| 13F-HR | 2016-05-16 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View Belmont Global Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.